For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Vedanta Biosciences, Inc.

USPTO Granted Patents = 16

EPO Patents = 2

Trademarks = 2

Forward Citations = 79

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Bernat Olle (12 out of 13 patents)

Shilpa Reddy (10 out of 10 patents)

Jason Norman (8 out of 8 patents)

4. Jessica Schneider (7 out of 7 patents)

5. Yun-Gi Kim (7 out of 7 patents)

6. Juan Patarroyo (7 out of 7 patents)

7. Bruce Roberts (3 out of 3 patents)

8. Daniel E Couto (3 out of 3 patents)

9. Jil Ulrich (3 out of 3 patents)

10. Scott Michonski (3 out of 3 patents)

11. Kenya Honda (2 out of 40 patents)

12. Takeshi Tanoue (2 out of 34 patents)

13. Koji Atarashi (2 out of 36 patents)

14. Hiroshi Ohno (2 out of 135 patents)

15. Rose L Szabady (2 out of 2 patents)

16 patents: Sort by Forward Citations

1. 12460175 - Methods and compositions for preserving bacteria (2025-11-04),

2. 12390498 - Treatment of clostridium difficile infection (2025-08-19),

3. 12161680 - Methods of decreasing dysbiosis and restoring a microbiome (2024-12-10),

4. 12053495 - Compositions and methods for suppressing pathogenic organisms (2024-08-06),

5. 11814615 - Methods and compositions for preserving bacteria (2023-11-14),

6. 11701396 - Treatment ofinfection (2023-07-18),

7. 11447738 - Methods and compositions for preserving bacteria (2022-09-20),

8. 11000556 - Compositions and methods for the treatment of allergy (2021-05-11),

9. 10555980 - Treatment ofinfection (2020-02-11),

10. 10507221 - Compositions and methods for the treatment of allergy (2019-12-17),

11. 10456431 - Treatment of clostridium difficile infection (2019-10-29),

12. 10350250 - Treatment of clostridium difficile infection (2019-07-16),

13. 10130695 - Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease (2018-11-20),

14. 10064904 - [object Object] (2018-09-04),

15. 9999641 - Treatment of clostridium difficile infection (2018-06-19),

Vedanta Biosciences, Inc. is a leading, clinical-stage biopharmaceutical company focused on developing a new category of therapies derived from the human microbiome. The company's platform is based on specialized consortia of bacteria, which are designed to restore the functionality of a healthy microbiota. Vedanta Biosciences' pioneering approach has the potential to address a range of diseases, including autoimmune, infectious, and allergic conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#139 in Cambridge, MA

#1,162 in Massachusetts

#19,309 in US

#36,682 in the World

Cambridge, MA, United States of America

Vedanta Biosciences, Inc.

Forward Citations = 79

20 inventors:

Bernat Olle (12 out of 13 patents)

Shilpa Reddy (10 out of 10 patents)

Jason Norman (8 out of 8 patents)

4. Jessica Schneider (7 out of 7 patents)

5. Yun-Gi Kim (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…